Spatial Omics Market Size, Share, Industry Forecast, 2032

Spatial Omics Market

Spatial Omics Market - By Technique (Spatial Transcriptomic, Spatial Proteomics, and Spatial Genomics), By Product (Instrument, Software, and Consumables), By End-User (Academic Institutes, CROs, and Research Institutes), And By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Biotechnology Report Format : PDF Pages: 140 Report Code: ZMR-6492 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 390.68 Million USD 944.07 Million 10.3% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Spatial Omics Market, 2018–2028(USD Million)
    • 2.2. Spatial Omics Market: Snapshot
  • Chapter 3. Global Spatial Omics Market– End-User Analysis
    • 3.1. Spatial Omics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increase in acceptance of spatial genomics by start-ups and small organizations along with its huge utilization in biomarker identification will drive market trends.
      • 3.2.2. Rise in application of spatial genomics in drug development and discovery will boost spatial omics industry in near future.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By End-User
      • 3.4.2. Market attractiveness analysis By Technique
      • 3.4.3. Market attractiveness analysis By Product
  • Chapter 4. Global Spatial Omics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Spatial Omics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Biotechnulogy launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Spatial Omics Market– End-User Analysis
    • 5.1. Global Spatial Omics Market overview: By End-User
      • 5.1.1. Global Spatial Omics Market share, By End-User , 2020 and 2028
    • 5.2. Academic Institutes
      • 5.2.1. Global Spatial Omics Market by Academic Institutes, 2018–2028(USD Million)
    • 5.3. CROs
      • 5.3.1. Global Spatial Omics Market by CROs, 2018–2028(USD Million)
    • 5.4. Research Institutes
      • 5.4.1. Global Spatial Omics Market by Research Institutes, 2018–2028(USD Million)
  • Chapter 6. Global Spatial Omics Market– Technique Analysis
    • 6.1. Global Spatial Omics Market overview: By Technique
      • 6.1.1. Global Spatial Omics Market share, By Technique, 2020 and 2028
    • 6.2. Spatial Transcriptomic
      • 6.2.1. Global Spatial Omics Market by Spatial Transcriptomic, 2018–2028(USD Million)
    • 6.3. Spatial Genomics
      • 6.3.1. Global Spatial Omics Market by Spatial Genomics, 2018–2028(USD Million)
    • 6.4. Spatial Proteomics
      • 6.4.1. Global Spatial Omics Market by Spatial Proteomics, 2018–2028(USD Million)
  • Chapter 7. Global Spatial Omics Market– Product Analysis
    • 7.1. Global Spatial Omics Market overview: By Product
      • 7.1.1. Global Spatial Omics Market share, By Product, 2020 and 2028
    • 7.2. Instrument
      • 7.2.1. Global Spatial Omics Market by Instrument, 2018–2028(USD Million)
    • 7.3. Software
      • 7.3.1. Global Spatial Omics Market by Software, 2018–2028(USD Million)
    • 7.4. Consumables
      • 7.4.1. Global Spatial Omics Market by Consumables, 2018–2028(USD Million)
  • Chapter 8. Company Profiles
    • 8.1. PerkinElmer, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Biotechnulogy Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Dovetail Genomics
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Biotechnulogy Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. IonPath, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Biotechnulogy Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Nanostring Technulogies, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Biotechnulogy Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Seven Bridges Genomics
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Biotechnulogy Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Danaher Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Biotechnulogy Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Bio-Techne
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Biotechnulogy Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Akoya Biosciences, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Biotechnulogy Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Diagenode Diagnostics
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Biotechnulogy Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. S2 Genomics, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Biotechnulogy Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Biognosys AG
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Biotechnulogy Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Vizgen Corporation
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Biotechnulogy Portfolio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development
    • 8.13. Bruker Corporation
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Biotechnulogy Portfolio
      • 8.13.4. Business Strategy
      • 8.13.5. Recent Development
    • 8.14. Brooks Automation, Inc.
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Biotechnulogy Portfolio
      • 8.14.4. Business Strategy
      • 8.14.5. Recent Development
    • 8.15. Rebus Biosystems
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Biotechnulogy Portfolio
      • 8.15.4. Business Strategy
      • 8.15.5. Recent Development
    • 8.16. BioSpyder Technulogies
      • 8.16.1. Overview
      • 8.16.2. Financials
      • 8.16.3. Biotechnulogy Portfolio
      • 8.16.4. Business Strategy
      • 8.16.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Spatial Omics Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Spatial Omics Marketattractiveness, By End-User
6. Global Spatial Omics Marketattractiveness, By Technique
7. Global Spatial Omics Marketattractiveness, By Product
8. Global Spatial Omics Marketshare by End-User ,2020 and 2028 (USD Million)
9. Global Spatial Omics Marketby Academic Institutes, 2018–2028(USD Million)
10. Global Spatial Omics Marketby CROs, 2018–2028(USD Million)
11. Global Spatial Omics Marketby Research Institutes, 2018–2028(USD Million)
12. Global Spatial Omics Marketshare by Technique ,2020 and 2028 (USD Million)
13. Global Spatial Omics Marketby Spatial Transcriptomic, 2018–2028(USD Million)
14. Global Spatial Omics Marketby Spatial Genomics, 2018–2028(USD Million)
15. Global Spatial Omics Marketby Spatial Proteomics, 2018–2028(USD Million)
16. Global Spatial Omics Marketshare by Product ,2020 and 2028 (USD Million)
17. Global Spatial Omics Marketby Instrument, 2018–2028(USD Million)
18. Global Spatial Omics Marketby Software, 2018–2028(USD Million)
19. Global Spatial Omics Marketby Consumables, 2018–2028(USD Million)
20. Global Spatial Omics Marketshare, by Region, 2020 and 2028
21. North America Spatial Omics Market, 2018–2028(USD Million)
22. Europe Spatial Omics Market, 2018–2028(USD Million)
23. Asia Pacific Spatial Omics Market, 2018–2028(USD Million)
24. Latin America Spatial Omics Market, 2018–2028(USD Million)
25. The Middle East and Africa Spatial Omics Market, 2018–2028(USD Million)
 


Table Of Tables

List of Tables

1. Global Spatial Omics Market: snapshot
2. Drivers of the Spatial Omics Market: impact analysis
3. North America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
4. North America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
5. North America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
6. The U.S. Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
7. The U.S. Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
8. The U.S. Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
9. Rest of North America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
10. Rest of North America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
11. Rest of North America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
12. Europe Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
13. Europe Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
14. Europe Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
15. UK Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
16. UK Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
17. UK Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
18. France Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
19. France Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
20. France Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
21. Germany Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
22. Germany Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
23. Germany Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
24. Rest of Europe Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
25. Rest of Europe Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
26. Rest of Europe Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
27. Asia Pacific Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
28. Asia Pacific Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
29. Asia Pacific Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
30. China Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
31. China Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
32. China Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
33. Japan Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
34. Japan Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
35. Japan Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
36. India Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
37. India Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
38. India Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
39. Rest of Asia Pacific Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
40. Rest of Asia Pacific Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
41. Rest of Asia Pacific Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
42. Latin America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
43. Latin America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
44. Latin America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
45. Brazil Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
46. Brazil Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
47. Brazil Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
48. Rest of Latin America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
49. Rest of Latin America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
50. Rest of Latin  America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
51. The Middle East and Africa Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
52. The Middle East and Africa Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
53. The Middle East and Africa Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
54. Saudi Arabia Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
55. Saudi Arabia Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
56. Saudi Arabia Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
57. South Africa Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
58. South Africa Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
59. South Africa Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
60. Rest of the Middle East & Africa Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
61. Rest of the Middle East & Africa Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
62. Rest of the Middle East & Africa Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)

 
  
 

Methodology

FrequentlyAsked Questions

Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive market trends. In addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry in foreseeable future. Rise in allocation of funds in biopharmaceutical sector will enlarge application scope of spatial omics in upcoming years.

According to Zion market research report, the global Spatial Omics Market was valued at USD 390.68 Million in 2023 and is projected to hit USD 944.07 Million by 2032, with a compound annual growth rate (CAGR) of 10.3% during the forecast period 2024-2032.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to rise in cancer cases along with escalating necessity of personalized drugs.

The key market participants include PerkinElmer, Inc., Dovetail Genomics, IonPath, Inc., Nanostring Technologies, Inc., Seven Bridges Genomics, Danaher Corporation, Bio-Techne, Akoya Biosciences, Inc., Diagenode Diagnostics, S2 Genomics, Inc., Biognosys AG, Vizgen Corporation, Bruker Corporation, Brooks Automation, Inc., BioSpyder Technologies, and Rebus Biosystems.

Spatial omics studies molecular data in tissue context. It helps understand disease at cellular levels
The global Spatial Omics market is expected to be driven by the advancements in precision medicine and cancer research. Demand for high-resolution molecular analysis supports market expansion.
According to study, the global Spatial Omics market size was worth around USD 390.68 Million in 2023 and is predicted to grow to around USD 944.07 Million By 2032.
The global Spatial Omics market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 10.3% during the forecast period from 2024-2032.
The global Spatial Omics industry is projected to be challenged by Challenges include high technology costs, data complexity, and limited skilled professionals.
The Opportunities include precision medicine, cancer research, drug discovery, and advanced biological insights will offer significant growth opportunities in the Spatial Omics market.
High-resolution tissue mapping technologies; integration of genomics and proteomics; applications in oncology and drug discovery are the emerging trends and innovations impacting the Spatial Omics market.
The global Spatial Omics market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Spatial Omics market are; PerkinElmer, Inc., Dovetail Genomics, IonPath, Inc., Nanostring Technologies, Inc., Seven Bridges Genomics, Danaher Corporation, Bio-Techne, Akoya Biosciences, Inc., Diagenode Diagnostics, S2 Genomics, Inc., Biognosys AG, Vizgen Corporation, Bruker Corporation, Brooks Automation, Inc., BioSpyder Technologies, and Rebus Biosystems and others.
The report explores crucial aspects of the Spatial Omics market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

HappyClients